Income StatementBalance SheetCash FlowSegments
Cardinal Health logo

Cardinal Health Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Cardinal Health holds $56.7B in total assets. Shareholders' equity is -$2.8B against $8.9B in total debt. Cash and equivalents total $3.9B. The current ratio is 0.906 and debt-to-equity is -3.15. Based on the Q1 2026 filing.

Total Assets$56.7BTotal Stockholders Equity-$2.8BLong Term Debt$8.9BCash And Equivalents$3.9BTotal Current Assets$38.1BTotal Current Liabilities$42.0B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$43.6B
P/E Ratio28.07
ROE-53.81%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$31.3B$32.8B$34.7B$36.9B$39.0B$37.8B
Current Portion of Long-Term Debt and Finance Lease Obligations$544.0M$543.0M$550.0M$52.0M$680.0M$671.0M
Total current liabilities$35.2B$36.7B$38.9B$40.3B$43.3B$42.0B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$12.4B$12.7B$13.2B$13.8B$13.7B$13.6B
Assets held for sale$50.0M$47.0M$12.0M$13.0M$0.0$0.0
Cash and cash equivalents$3.8B$3.3B$3.9B$4.6B$2.8B$3.9B
Other current assets$2.6B$2.4B$2.4B$2.6B$2.7B$2.5B
Inventories$16.9B$16.2B$16.8B$17.6B$20.1B$18.0B
Total current assets$35.8B$34.6B$36.4B$38.5B$39.2B$38.1B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accumulated other comprehensive income (loss)-$180.0M-$176.0M-$155.0M-$159.0M-$153.0M-$161.0M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$2.9B$2.9B$3.0B$2.7B$2.8B$2.8B
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Treasury Stock, Value$6.0B$6.4B$6.4B$6.6B$7.0B$7.2B
Retained earnings$283.0M$664.0M$783.0M$1.1B$1.5B$1.7B
Total liabilities and stockholders' equity$47.0B$49.9B$53.1B$55.2B$58.1B$56.7B
Total stockholders' equity-$3.0B-$2.9B-$2.8B-$2.9B-$2.9B-$2.8B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Goodwill$5.5B$8.9B$9.7B$9.7B$11.6B$11.4B
Indefinite-Lived Intangible Assets$12.0M$13.0M$13.0M$14.0M$14.0M$25.0M
Intangible assets — net$1.9B$2.1B$2.5B$2.4B$2.4B$2.3B
Other intangible assets—net$1.9B$2.1B$2.5B$2.4B$2.4B$2.3B
Goodwill and intangible assets, net$7.4B$11.0B$12.2B$12.1B$14.0B$13.7B
Other non-current assets$1.3B$1.6B$1.7B$1.8B$2.0B$2.0B
Property and equipment, net$2.6B$2.7B$2.9B$2.8B$2.9B$2.9B
Total assets$47.0B$49.9B$53.1B$55.2B$58.1B$56.7B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Long-term debt$7.6B$7.7B$8.5B$9.0B$9.0B$8.9B
Hybrid debt$137.0M$175.0M$213.0M$218.0M$215.0M$203.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Carrying Amount of Long-Term and other Short-Term Borrowings$7.6B$7.7B$8.5B$9.0B$9.0B$8.9B
Common stock, shares authorized (in shares)755M755M755M755M755M755M
Common stock, shares issued (in shares)271M271M271M271M271M271M
Deferred Tax and Other Liabilities, Noncurrent$7.6B$8.0B$8.9B$8.7B$9.1B$9.1B
Finite-Lived Intangible Assets, Accumulated Amortization$3.7B$3.7B$3.8B$3.9B$4.0B$4.1B
2028$240.0M$285.0M—$330.0M$349.0M$349.0M
2030$208.0M$249.0M—$284.0M$306.0M$306.0M
Remainder of 2026$144.0M$82.0M—$269.0M$193.0M$97.0M
2027$267.0M$308.0M—$366.0M$382.0M$382.0M
2029$213.0M$256.0M—$307.0M$327.0M$327.0M
Gross Carrying Amount$5.6B$5.8B$6.3B$6.3B$6.4B$6.4B
Indefinite- lived intangible impairment$5.6B$5.9B$6.3B$6.3B$6.4B$6.4B
Long-Term Debt and Lease Obligation$7.1B$7.1B$8.0B$9.0B$8.3B$8.2B
2028$545.0M$548.0M—$1.9B$1.9B$1.9B
2029$1.9B$1.9B—$837.0M$839.0M$740.0M
2029$658.0M$663.0M—$766.0M$766.0M$768.0M
2030$21.0M$27.0M—$674.0M$674.0M$676.0M
Thereafter$4.5B$4.6B—$4.9B$4.8B$4.8B
2027$24.0M$12.0M—$42.0M$27.0M$14.0M
Loss Contingency Estimate Of Possible Loss—————$160.0M
Noncontrolling interests in subsidiaries$70.0M$1.1B$147.0M$148.0M$184.0M$160.0M
Other accrued liabilities$3.4B$3.3B$3.6B$3.4B$3.6B$3.5B
Preferred Stock, Shares Authorized500K500K500K500K500K500K
Preferred Stock, Shares Issued000000
Restructuring Reserve$75.0M$82.0M$79.0M$71.0M$76.0M$73.0M
Incentive stock program, shares reserved for future grants (in shares)—15M——16M16M
Total Long-Term and Short-Term Obligations$7.6B$7.7B$8.5B—$9.0B$8.9B
Treasury stock, shares (in shares)29M32M32M33M35M36M
Unrecognized tax benefits$924.0M$890.0M$879.0M$894.0M$903.0M$906.0M
Penalties and interest accrued on unrecognized tax benefits$74.0M$64.0M$65.0M$70.0M$77.0M$72.0M
Amount that if recognized, would affect the effective tax rate or regulatory liability$860.0M$865.0M$871.0M$877.0M$877.0M$880.0M